Ignite Creation Date:
2025-12-24 @ 10:10 PM
Ignite Modification Date:
2026-01-04 @ 12:03 PM
Study NCT ID:
NCT05996835
Status:
RECRUITING
Last Update Posted:
2025-12-23
First Post:
2023-08-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (CLEAR-AKI)
Sponsor:
Novartis Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Acute Kidney Injury Due to Sepsis | View |